Pfizer, BioNTech to co-develop potential coronavirus vaccine
Pfizer already collaborates with BioNTech to develop mRNA-based vaccines for influenza
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Pfizer
Pfizer identifies antiviral compounds with potential as coronavirus treatments
The company hopes to start testing them by the end of the year if any of the compounds are successful
Pfizer has identified…
Pfizer Q3 net profit up 5 per cent to Rs 139 crore
Pfizer reported a 5.39 per cent rise in net profit to Rs 139.06 crore for the quarter ended December 31, 2019. The company had…
Biogen to buy early-stage potential Alzheimer’s, Parkinson’s treatment from Pfizer
Under the deal, Pfizer will get $75 million upfront and will be eligible for $635 million in potential milestone payments
Drugmakers from Pfizer to GSK to hike US prices on over 200 drugs
More price increases are expected to be announced later this week, which could affect the median and range
US FDA declines to approve GSK drugs division’s long acting HIV injection
ViiV, in which Pfizer and Shionogi have small stakes, said it received a so-called complete response letter (CRL) from the FDA in…
Pfizer, Mylan announce two future Viatris Board Members
Ian Read and James Kilts offer strong experience to support long-term value creation
Pfizer and Mylan announced that Ian Read…
Dr Reddy’s Labs launches generic injection indicated for abortion in US
The company has launched Carboprost Tromethamine injection USP, 250 mcg/mL (1mL) single-dose vial in the US market
Mylan and Pfizer announce Viatris as the new company name in the planned Mylan-Upjohn combination
Formed through a combination of two complementary businesses, Viatris will unite Upjohn’s strong leadership position in China and…
InvaGen receives final approval for Pregabalin Capsules
InvaGen’s Pregabalin Capsule is AB-rated generic therapeutic equivalent version of Pfizer’s Lyrica